SEC Form 4 · accession 0000898432-19-000013
IRADIMED CORP · IRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven M. Nardi
Officer — VP MANUFACTURING
Period of report
Dec 31, 2018
Accepted (ET)
Jan 3, 2019 · 5:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 31, 2018 | M | 388 | — | A | 1,513 | D | |
| Common Stock | Dec 31, 2018 | F | 95 | $24.46 | D | 1,418 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Dec 31, 2018 | M | 388 | D | — | — | Common Stock | 388 | 388 | D |
Explanation of responses
- F1Restricted stock units convert into common stock on a one-for-one basis.
- F2On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2019 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.